1. Improving the accuracy of predicted human pharmacokinetics: lessons learned from the astrazeneca drug pipeline over two decades;Davies;Trends Pharmacol Sci,2020
2. Evaluation of the success of High-Throughput Physiologically Based Pharmacokinetic (HT-PBPK) modeling predictions to inform early drug discovery;Naga;Mol Pharm,2022
3. Chung T.D.Y., Terry D.B., Smith L.H. In vitro and in vivo assessment of ADME and PK properties during lead selection and lead optimization – guidelines, benchmarks and rules of thumb. In: Markossian S., Grossman A., Brimacombe K., et al., eds.; 2004.
4. Estimating human ADME properties, pharmacokinetic parameters and likely clinical dose in drug discovery;Lucas;Expert Opin Drug Discov,2019
5. Evaluation of generic methods to predict human pharmacokinetics using physiologically based pharmacokinetic model for early drug discovery of tyrosine kinase inhibitors;Ren;Eur J Drug Metab Pharmacokinet,2019